Recombinant Human Follicle Stimulating Hormone(Bogene/Chengdu Zeyan Biotech)

重组人促卵泡激素（博发生物/成都景泽生物）

Report date: 2026/05/26 20:00:28

Base Information

Drug NameRecombinant Human Follicle Stimulating Hormone(Bogene/Chengdu Zeyan Biotech)
Drug Alias Name泽盼喜JZB30
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionFollicle-stimulating hormone receptor agonists
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsIdiopathie hypogonadotropic hypogonadismInfertility, FemaleAnovulation +[5] 
Global Approved IndicationsIdiopathie hypogonadotropic hypogonadism
Approved Indications in ChinaIdiopathie hypogonadotropic hypogonadism
Original Approved Country/TerritoryMainland China
Original Approved Date2025/04/30
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Jingze Biotechnology Co LtdChengdu Bofa Biotechnology Co LtdTianjin Bogene Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jingze Biotechnology Co LtdChengdu Bofa Biotechnology Co LtdChengdu Zeyan Biotechnology Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsIdiopathie hypogonadotropic hypogonadismInfertility, FemaleAnovulation +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A